Evaluation of hormonal changes in women on erlotinib therapy.
Phase of Trial: Phase II
Latest Information Update: 14 Apr 2011
At a glance
- Drugs Erlotinib (Primary)
- Indications Non-small cell lung cancer
- Focus Pharmacodynamics
- 31 Aug 2018 Biomarkers information updated
- 14 Apr 2011 Actual end date (Aug 2009) added as reported by ClinicalTrials.gov.
- 14 Apr 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.